Machoy-Mokrzyńska, A.; Rać, M.; Jurewicz, A.; Dziedziejko, V.; Safranow, K.; Kurzawski, M.; Boroń, A.; Stefaniak, A.; Leźnicka, K.; Bohatyrewicz, A.;
et al. Lack of Association between (AAT)n Polymorphism of the CNR1 Gene Encoding the Cannabinoid Receptor (CB1) and Patient’s Quality of Life. Genes 2022, 13, 2046.
https://doi.org/10.3390/genes13112046
AMA Style
Machoy-Mokrzyńska A, Rać M, Jurewicz A, Dziedziejko V, Safranow K, Kurzawski M, Boroń A, Stefaniak A, Leźnicka K, Bohatyrewicz A,
et al. Lack of Association between (AAT)n Polymorphism of the CNR1 Gene Encoding the Cannabinoid Receptor (CB1) and Patient’s Quality of Life. Genes. 2022; 13(11):2046.
https://doi.org/10.3390/genes13112046
Chicago/Turabian Style
Machoy-Mokrzyńska, Anna, Monika Rać, Alina Jurewicz, Violetta Dziedziejko, Krzysztof Safranow, Mateusz Kurzawski, Agnieszka Boroń, Arkadiusz Stefaniak, Katarzyna Leźnicka, Andrzej Bohatyrewicz,
and et al. 2022. "Lack of Association between (AAT)n Polymorphism of the CNR1 Gene Encoding the Cannabinoid Receptor (CB1) and Patient’s Quality of Life" Genes 13, no. 11: 2046.
https://doi.org/10.3390/genes13112046
APA Style
Machoy-Mokrzyńska, A., Rać, M., Jurewicz, A., Dziedziejko, V., Safranow, K., Kurzawski, M., Boroń, A., Stefaniak, A., Leźnicka, K., Bohatyrewicz, A., & Białecka, M.
(2022). Lack of Association between (AAT)n Polymorphism of the CNR1 Gene Encoding the Cannabinoid Receptor (CB1) and Patient’s Quality of Life. Genes, 13(11), 2046.
https://doi.org/10.3390/genes13112046
